Dr. Lyn Dyster ’80 has devoted her life to fighting cancer and other debilitating disorders through ground-breaking research and drug discovery. She has helped develop new breast cancer diagnostic and therapeutic technologies and is a founder of Kinex Pharmaceuticals, a biotech firm that is developing break-through medicines for cancer, osteoporosis, hearing loss, obesity, and ischemic disease.
She is a graduate of Washington and Jefferson College and later earned a Ph.D. in biochemistry from the University at Buffalo.